Status:
UNKNOWN
Comparative Study of SR Bupropion for Adolescent Smoking Cessation
Lead Sponsor:
Geha Mental Health Center
Conditions:
Smoking
Smoking Cessation
Eligibility:
All Genders
13-20 years
Phase:
NA
Brief Summary
Bupropion has been used successfully and safely for smoking cessation in adults. It was also used in very few studies among adolescent population. Our hypothesis is that Bupropion would be effective a...
Detailed Description
The study will be conducted in Geha Mental Health Center. A total of 80 adolescent non-psychotic smokers will be recruited for this study. A smoker is defined as a cosumer of at least 5 cigarettes dai...
Eligibility Criteria
Inclusion
- adolescents (age 13-20)
- daily smokers (over 5 cigarettes daily)
- have motivation to quit
- nonpsychotic
- treated in out MHC
Exclusion
- Psychiatric disorders in Axis I of DSM IV (38) (for the control group)
- Smoking less than 6 cigarettes a day
- Using other tobacco products other than cigarettes
- Using any other smoking cessation treatment
- Exhaled CO level of less than 10 ppm
- Convulsive disorder or a history of seizures
- A first-degree relative with a convulsive disorder
- Past sensitivity to bupropion.
- Positive pregnancy test
- lactation
- A lack of motivation to quit smoking
- Alcohol and substance abuse (or current alcohol withdrawal)
- Mental retardation and a lack of ability to give an informed consent
- Concurrent use of Monoamine oxidase inhibitors (MAO-I).
- Anorexia nervosa or bulimia nervosa.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00819078
Start Date
January 1 2009
End Date
January 1 2014
Last Update
January 8 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geha Mental Health Center
Petah Tikva, Israel